Literature DB >> 28708453

Virulence and Antibiotic Resistance of Enterococci Isolated from Healthy Breastfed Infants.

José M Landete1, Ángela Peirotén1, Margarita Medina1, Juan L Arqués1, Eva Rodríguez-Mínguez1.   

Abstract

Pathogenic ability has been extensively studied in clinical enterococci, but to a lesser extent in community-derived ones. Most studies to date in enterococci from healthy infants have been focused on Enterococcus faecalis, despite the growing concern about nosocomial infections caused by E. faecium. In this work, we studied the antibiotic resistance and virulence determinants of 26 E. faecalis and 15 E. faecium intestinal isolates from Spanish healthy breastfed infants. Overall, commensal enterococci studied contained antibiotic resistance and virulence genes, although their patterns were not according to those described for antibiotic-resistant hospital-associated enterococci. None of the isolates was resistant to vancomycin, although the majority showed resistance to some antibiotics. E. faecalis isolates harbored considerably more virulence determinants than E. faecium isolates, but some genes linked to colonization were abundant in both species. Hemolysin activity was not detected in any of the isolates; and the gelatinase gene, when present, was silent in E. faecium, whereas gelatinase activity occurred in half of the E. faecalis isolates studied. These results suggest an ambivalent role of some virulence determinants as elements of pathogenesis.

Entities:  

Keywords:  antibiotic resistance; breastfed infants; enterococci; intestinal microbiota; virulence determinants

Mesh:

Substances:

Year:  2017        PMID: 28708453     DOI: 10.1089/mdr.2016.0320

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  Enterococci as Intestinal Microbiota: Investigation of Characteristics and Probiotic Potential in Isolates from Adults and Breast-Fed Infants.

Authors:  Maryam Rahmani; Fereshteh Saffari; Eugen Domann; Kurt Zimmermann; Ladan Langroudi; Shahla Mansouri
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-18       Impact factor: 4.609

Review 2.  Biofilm-associated infection by enterococci.

Authors:  Jun-Hong Ch'ng; Kelvin K L Chong; Ling Ning Lam; Jun Jie Wong; Kimberly A Kline
Journal:  Nat Rev Microbiol       Date:  2019-01       Impact factor: 60.633

3.  A potentially probiotic strain of Enterococcus faecalis from human milk that is avirulent, antibiotic sensitive, and nonbreaching of the gut barrier.

Authors:  Jasia Anjum; Arsalan Zaidi; Kim Barrett; Muhammad Tariq
Journal:  Arch Microbiol       Date:  2022-02-02       Impact factor: 2.552

4.  Antimicrobial Resistance, Virulence Genes, and Biofilm Formation Capacity Among Enterococcus species From Yaks in Aba Tibetan Autonomous Prefecture, China.

Authors:  Pengfei Cui; Lan Feng; Lan Zhang; Juan He; Tianwu An; Xue Fu; Cui Li; Xiaodong Zhao; Yaru Zhai; Hao Li; Wenjun Yan; Huade Li; Xiaolin Luo; Changwei Lei; Hongning Wang; Xin Yang
Journal:  Front Microbiol       Date:  2020-06-12       Impact factor: 5.640

5.  Effects of artificially introduced Enterococcus faecalis strains in experimental necrotizing enterocolitis.

Authors:  Patrick T Delaplain; Brandon A Bell; Jin Wang; Mubina Isani; Emily Zhang; Christopher P Gayer; Anatoly V Grishin; Henri R Ford
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

Review 6.  Advances and Prospects in Vaccine Development against Enterococci.

Authors:  Ermioni Kalfopoulou; Johannes Huebner
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

Review 7.  Human Milk Microbiota and Oligosaccharides: A Glimpse into Benefits, Diversity, and Correlations.

Authors:  Carole Ayoub Moubareck
Journal:  Nutrients       Date:  2021-03-29       Impact factor: 5.717

8.  Antimicrobial Resistance and Virulence Factor Gene Profiles of Enterococcus spp. Isolated from Giant Panda Oral Cavities.

Authors:  Rui Zhong; Ziyao Zhou; Haifeng Liu; Zhijun Zhong; Guangneng Peng
Journal:  J Vet Res       Date:  2021-06-08       Impact factor: 1.744

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.